Current
$169.59M
5-Year Average
$160.19M
All-Time High
$458.20M
All-Time Low
$18.11M
Market cap daily chart for Ovid Therapeutics (OVID)
Jun 14, 2021 – Jun 12, 2026 · 1,256 trading days
Market Cap growth chart for Ovid Therapeutics (OVID) from 2017 to 2026
Latest: +41.1%
Market Cap history table for Ovid Therapeutics (OVID) from 2017 to 2026
| 2026 | $169.59M | +41.1% | +$49.40M | ||
| 2025 | $120.19M | +81.5% | +$53.99M | ||
| 2024 | $66.20M | -70.9% | −$161.07M | ||
| 2023 | $227.27M | +73.5% | +$96.28M | ||
| 2022 | $130.99M | -40.0% | −$87.51M | ||
| 2021 | $218.50M | +61.8% | +$83.48M | ||
| 2020 | $135.02M | -17.0% | −$27.73M | ||
| 2019 | $162.75M | +173.0% | +$103.14M | ||
| 2018 | $59.61M | -68.8% | −$131.32M | ||
| 2017 | $190.93M | — | — |
- 2026$169.59M+41.1%
- 2025$120.19M+81.5%
- 2024$66.20M-70.9%
- 2023$227.27M+73.5%
- 2022$130.99M-40.0%
- 2021$218.50M+61.8%
- 2020$135.02M-17.0%
- 2019$162.75M+173.0%
- 2018$59.61M-68.8%
- 2017$190.93M—
Market Cap values are taken from Ovid Therapeutics's reported income statements (share counts) and end-of-day prices (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Market Cap at Ovid Therapeutics (OVID)
According to Ovid Therapeutics's latest reported financial statements, the company's latest reported market cap is $163.69M. Market capitalization is the total dollar value of all outstanding shares — shares outstanding × stock price — and the standard measure of a company's equity value. On this page, historical market cap snaps filing-period share counts to closing prices on or before each statement date (not intraday tick data).
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
2026's annual market cap for Ovid Therapeutics (OVID) came in at $169.59M – surged 41.1% year-over-year.
Ovid Therapeutics market cap has grown for 2 consecutive years, with a -4.9% compound annual growth rate over 2021–2026 (5 years).
Between 2023 and 2026, Ovid Therapeutics market cap declined 25.4%, falling from $227.27M to $169.59M.
The record annual market cap stands at $227.27M, reached in 2023; the historical low of $59.61M was recorded in 2018.
Ovid Therapeutics Market Cap by Year
Ovid Therapeutics Market Cap 2026: $169.59M
Ovid Therapeutics posted market cap of $169.59M in 2026, surged 41.1% from 2025.
Ovid Therapeutics Market Cap 2025: $120.19M
In 2025, Ovid Therapeutics reported market cap of $120.19M, surged 81.5% from 2024.
Ovid Therapeutics Market Cap 2024: $66.20M
Ovid Therapeutics market cap in 2024 was $66.20M, plunged 70.9% below 2023.
Ovid Therapeutics Market Cap 2023: $227.27M
2023's market cap for Ovid Therapeutics came in at $227.27M, surged 73.5% from 2022. This figure represents the highest annual value in the available history.
Ovid Therapeutics Market Cap 2022: $130.99M
Ovid Therapeutics market cap in 2022 was $130.99M.
See more financial history for Ovid Therapeutics (OVID).
Sector peers by Market Cap
Healthcare peers of Ovid Therapeutics (OVID), ranked by their latest market cap
| $1.07T | |
| $579.83B | |
| $402.35B | |
| $371.00B | |
| $294.03B | |
| $277.22B | |
| $194.99B | |
| $191.70B |
- $1.07T
- $579.83B
- $402.35B
- $371.00B
- $294.03B
- $277.22B
- $194.99B
- $191.70B
Frequently asked questions
Ovid Therapeutics (OVID) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation